Cargando…

Vitreous estrogen levels in patients with an idiopathic macular hole

PURPOSE: Estrogen, a female hormone, activates collagenase and might be associated with the pathogenesis of vitreoretinal collagen fiber disease. The purpose of the present study was to investigate the vitreous levels of estrone (E1) and estradiol (E2) in subjects with an idiopathic macular hole (IM...

Descripción completa

Detalles Bibliográficos
Autores principales: Inokuchi, Naoki, Ikeda, Tsunehiko, Nakamura, Kimitoshi, Morishita, Seita, Fukumoto, Masanori, Kida, Teruyo, Oku, Hidehiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4376308/
https://www.ncbi.nlm.nih.gov/pubmed/25848205
http://dx.doi.org/10.2147/OPTH.S80754
_version_ 1782363720979054592
author Inokuchi, Naoki
Ikeda, Tsunehiko
Nakamura, Kimitoshi
Morishita, Seita
Fukumoto, Masanori
Kida, Teruyo
Oku, Hidehiro
author_facet Inokuchi, Naoki
Ikeda, Tsunehiko
Nakamura, Kimitoshi
Morishita, Seita
Fukumoto, Masanori
Kida, Teruyo
Oku, Hidehiro
author_sort Inokuchi, Naoki
collection PubMed
description PURPOSE: Estrogen, a female hormone, activates collagenase and might be associated with the pathogenesis of vitreoretinal collagen fiber disease. The purpose of the present study was to investigate the vitreous levels of estrone (E1) and estradiol (E2) in subjects with an idiopathic macular hole (IMH). METHODS: Vitreous samples were obtained from ten female patients with an IMH and from nine female patients with other retinal diseases (six with rhegmatogenous retinal detachment and three with age-related macular degeneration) as a control at the time of vitreous surgery. E1 and E2 levels in the vitreous samples were then determined using the Coat-A-Count(®) Estradiol Radioimmunoassay (RIA) Kit and the DSL-70 Estrone RIA Kit, respectively. RESULTS: The mean vitreous levels of E1 and E2 in the subjects with IMH were 1.83±2.00 pg/mL and 7.03±2.97 pg/mL, respectively, whereas in the control subjects they were 2.42±1.25 pg/mL and 4.90±2.90 pg/mL, respectively. Thus, the vitreous E2 levels in the subjects with IMH were significantly higher than in the controls (P<0.05). CONCLUSION: The findings of this study suggest that E2 might be associated with the pathogenesis of IMH, but further investigation is needed to elucidate that association.
format Online
Article
Text
id pubmed-4376308
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-43763082015-04-06 Vitreous estrogen levels in patients with an idiopathic macular hole Inokuchi, Naoki Ikeda, Tsunehiko Nakamura, Kimitoshi Morishita, Seita Fukumoto, Masanori Kida, Teruyo Oku, Hidehiro Clin Ophthalmol Original Research PURPOSE: Estrogen, a female hormone, activates collagenase and might be associated with the pathogenesis of vitreoretinal collagen fiber disease. The purpose of the present study was to investigate the vitreous levels of estrone (E1) and estradiol (E2) in subjects with an idiopathic macular hole (IMH). METHODS: Vitreous samples were obtained from ten female patients with an IMH and from nine female patients with other retinal diseases (six with rhegmatogenous retinal detachment and three with age-related macular degeneration) as a control at the time of vitreous surgery. E1 and E2 levels in the vitreous samples were then determined using the Coat-A-Count(®) Estradiol Radioimmunoassay (RIA) Kit and the DSL-70 Estrone RIA Kit, respectively. RESULTS: The mean vitreous levels of E1 and E2 in the subjects with IMH were 1.83±2.00 pg/mL and 7.03±2.97 pg/mL, respectively, whereas in the control subjects they were 2.42±1.25 pg/mL and 4.90±2.90 pg/mL, respectively. Thus, the vitreous E2 levels in the subjects with IMH were significantly higher than in the controls (P<0.05). CONCLUSION: The findings of this study suggest that E2 might be associated with the pathogenesis of IMH, but further investigation is needed to elucidate that association. Dove Medical Press 2015-03-20 /pmc/articles/PMC4376308/ /pubmed/25848205 http://dx.doi.org/10.2147/OPTH.S80754 Text en © 2015 Inokuchi et al. This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution – Non Commercial (unported, v3.0) License The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.
spellingShingle Original Research
Inokuchi, Naoki
Ikeda, Tsunehiko
Nakamura, Kimitoshi
Morishita, Seita
Fukumoto, Masanori
Kida, Teruyo
Oku, Hidehiro
Vitreous estrogen levels in patients with an idiopathic macular hole
title Vitreous estrogen levels in patients with an idiopathic macular hole
title_full Vitreous estrogen levels in patients with an idiopathic macular hole
title_fullStr Vitreous estrogen levels in patients with an idiopathic macular hole
title_full_unstemmed Vitreous estrogen levels in patients with an idiopathic macular hole
title_short Vitreous estrogen levels in patients with an idiopathic macular hole
title_sort vitreous estrogen levels in patients with an idiopathic macular hole
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4376308/
https://www.ncbi.nlm.nih.gov/pubmed/25848205
http://dx.doi.org/10.2147/OPTH.S80754
work_keys_str_mv AT inokuchinaoki vitreousestrogenlevelsinpatientswithanidiopathicmacularhole
AT ikedatsunehiko vitreousestrogenlevelsinpatientswithanidiopathicmacularhole
AT nakamurakimitoshi vitreousestrogenlevelsinpatientswithanidiopathicmacularhole
AT morishitaseita vitreousestrogenlevelsinpatientswithanidiopathicmacularhole
AT fukumotomasanori vitreousestrogenlevelsinpatientswithanidiopathicmacularhole
AT kidateruyo vitreousestrogenlevelsinpatientswithanidiopathicmacularhole
AT okuhidehiro vitreousestrogenlevelsinpatientswithanidiopathicmacularhole